National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

HIV/AIDS
 Understanding
 Research
  Basic Science
  Epidemiology
  Prevention
  Therapeutics
   Introduction and Goals
   Research Activities
   Resources for Researchers
   Funding
   Meetings
   Clinical Trials
   Treatment Guidelines
  Vaccines


HIV/AIDS

Therapeutics

Clinical Trials

NIAID-Funded Clinical Research

NIAID pursues HIV/AIDS therapeutics clinical research through its Division of Intramural Research, individual investigator-initiated grants, and clinical trial networks administered by its Division of AIDS.

  • NIAID Division of Intramural Research (DIR)
    This division conducts all NIAID in-house research. DIR scientists carry out basic and clinical research in immunologic, allergic, and infectious diseases. Patients are frequently admitted to the clinical service to participate in new and promising treatment or diagnostic procedures derived from basic research that was conducted in DIR laboratories.
  • NIAID HIV/AIDS Clinical Trials Networks

Other NIH-Funded Clinical Trials Networks

(Non-Government Links)

Other networks working in collaboration with DAIDS on clinical research pertaining to adolescents and co-infections and complications of HIV respectively, include:

  • AIDS Malignancy Consortium (AMC) conducts clinical trials of therapies for AIDS malignancies, including non-Hodgkin's lymphoma, primary central nervous system lymphoma, Kaposi's sarcoma, and cervical cancer.
  • Adolescent Trials Network (ATN) is the only national study of HIV/AIDS in teens infected through sex or injecting-drug behaviors. Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), ATN research will be able to inform the nation’s adolescent-specific HIV/AIDS scientific agenda to improve the prevention of HIV infection and the medical treatment of HIV-positive teens.
  • Bacteriology and Mycology Study Group (BAMSG) directs trials for antimicrobial therapies of systemic fungal infections.
  • Collaborative Antiviral Study Group (CASG) conducts studies to evaluate experimental therapies for severe herpes, congenital cytomegalovirus (CMV), human papillomavirus, respiratory viruses, enteroviruses, and hepatitis viruses.
  • Neurology AIDS Research Consortium (NARC) conducts studies on HIV-associated neurological complications.
  • Studies of Ocular Complications of AIDS (SOCA) conducts clinical trials and epidemiological research on ocular complications of AIDS, primarily CMV retinitis.

AIDSinfo: The Department of Health and Human Services supports a comprehensive Web site with a database of all federally funded and privately sponsored HIV/AIDS clinical trials, as well as information on HIV/AIDS treatment and prevention guidelines, therapeutic and preventive drugs and vaccines, and other HIV/AIDS-related health topics can be found on Web site.

back to top


Highlights

25 Years of HIV/AIDS Science: Reaching the Poor with Research Advances (Commentary by NIAID Director Anthony S. Fauci published in Cell)—Nov. 2, 2007

See Also

  • Division of AIDS
  • Vaccine Research Center
  • HIV/AIDS Publications
  • HIV/AIDS News Releases
  • Global Research, Africa
  • Selected NIAID Science Advances, 2007-2008 (PDF)
  • Vaccines
  • E-mail Icon E-mail this page
    Print Icon Print this page
    Plug-ins and Viewers
    To open PDFs on this page, download and install the Adobe Acrobat Reader.

    Highlights

    25 Years of HIV/AIDS Science: Reaching the Poor with Research Advances (Commentary by NIAID Director Anthony S. Fauci published in Cell)—Nov. 2, 2007

    See Also

  • Division of AIDS
  • Vaccine Research Center
  • HIV/AIDS Publications
  • HIV/AIDS News Releases
  • Global Research, Africa
  • Selected NIAID Science Advances, 2007-2008 (PDF)
  • Vaccines